Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

Silence Therapeutics PLC

SLN
6,80
-0,30 (-4,23%)
Pre Mercato
Ultimo aggiornamento: 14:55:51
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
09/12/202414:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/12/202413:30BWSilence Therapeutics Presents Promising Phase 1 Data in..
26/11/202414:00BWSilence Therapeutics to Participate in Fireside Chat at..
18/11/202422:54EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/11/202420:30BWSilence Therapeutics Presents Late-Breaking Phase 2..
14/11/202419:13EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202415:44EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202415:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/11/202414:00BWSilence Therapeutics Reports Third Quarter 2024 Financial..
13/11/202414:00BWSilence Therapeutics to Participate in Fireside Chat at the..
27/8/202414:00BWSilence Therapeutics to Webcast Presentations at Upcoming..
15/8/202413:30BWSilence Therapeutics Reports Second Quarter 2024 Financial..
27/6/202413:30BWSilence Therapeutics Announces Positive Results from Ongoing..
24/6/202414:30BWSilence Therapeutics Achieves $2 Million Research Milestone..
20/6/202413:30BWSilence Therapeutics Announces Positive Topline 48-Week Data..
30/5/202414:30BWSilence Therapeutics to Present at Jefferies Global..
17/5/202423:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/5/202420:21EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/5/202414:30BWSilence Therapeutics Reports First Quarter 2024 Results and..
14/5/202422:27EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/5/202423:14EDGAR2Form DEL AM - Delaying amendment
30/4/202414:30BWSilence Therapeutics to Participate in Fireside Chat at H.C...
29/4/202414:30BWSilence Therapeutics Announces Retirement of Alistair Gray..
08/4/202417:48BWSilence Therapeutics Announces JAMA Publication of..
13/3/202412:05BWSilence Therapeutics Reports Full Year 2023 Financial..
13/3/202412:03IHMARKETNEWSMixed Futures Amidst Quiet Economic Schedule; Oil Prices..
13/3/202412:00BWSilence Therapeutics Announces Positive Topline 36-Week Data..
28/2/202414:00BWSilence Therapeutics to Report Fourth Quarter and Full Year..
23/2/202414:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/2/202414:00BWSilence Therapeutics Achieves $10 Million Milestone Payment..
14/2/202415:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/2/202414:00BWSilence Therapeutics Announces Oversubscribed $120 Million..
31/1/202413:00BWSilence Therapeutics to Participate in Fireside Chat at..
Apertura: Min: Max:
Chiusura: 7,10

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network